Open-Label Study

Following NIH clinical study guidelines, investigators in an open-label intervention study assess health outcomes in groups of participants according to a research plan or protocol in a non-clinical setting. Participants may receive interventions as part of their routine medical care and at the same time assigned to specific interventions by the investigators.
[Source: https://clinicaltrials.gov/ct2/about-studies, a service of the National Institute of Health]

What to expect when you enroll

Our current focus of study is assessing impact of chondroitin preparations on joint health. Enrolled participants will receive 30 servings of free chondroitin capsules for daily use and are expected to provide real-time health and joint condition assessments by responding to study questionnaires. Quantitative measurements will be taken on wellness, activity, and pain and discomfort scales, and compared and analyzed over a period of 4 to 12 weeks duration. Click here for more information.

Chondroitin capsules for study

For additional Chondroitin Pure 1000 or Chondroitin 1000+ capsules necessary for extended study period beyond 4 weeks, visit www.synutrapure.com to purchase with your exclusive iMember discount.

Enrollment Form

To access enrollment form click here.

Assessment Return

To access assessment return form click here.

中文表格

会员文件

注册成会员, 请点击这里

注册成中心会员, 请点击这里


软骨素干预研究

获取报名表,请点击这里

获取评估数据表,请点击这里